Real-world effectiveness of PARP inhibitors after CDK4/6 inhibitor therapy in BRCA-mutated HR-positive/HER2-negative advanced breast cancer
Year: 2025
Type: article
Language: en
Topic: Advanced Breast Cancer Therapies
Authors and affiliations:
raw_author_name: Emma Zattarin
raw_affiliation_strings: Department of Medical Oncology, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy
Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy
raw_author_name: Antonio Marra
raw_affiliation_strings: Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy
raw_author_name: Antonella Palazzo
raw_affiliation_strings: Department of Medical Oncology, Comprehensive Cancer Center, Agostino Gemelli University Polyclinic (IRCCS), Rome, Italy
raw_author_name: Gaia Griguolo
raw_affiliation_strings: Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy
Division of Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy
raw_author_name: Claudio Vernieri
raw_affiliation_strings: Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy
Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
raw_author_name: Julian Etessami
raw_affiliation_strings: Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy
raw_author_name: Letizia Pontolillo
raw_affiliation_strings: Department of Medical Oncology, Comprehensive Cancer Center, Agostino Gemelli University Polyclinic (IRCCS), Rome, Italy
Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medicine, New York, NY, USA
raw_author_name: Giusy Landa
raw_affiliation_strings: Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy
Division of Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy
raw_author_name: Arianna Daneri
raw_affiliation_strings: Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy
raw_author_name: Matteo De Monte
raw_affiliation_strings: Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy
Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
raw_author_name: Riccardo Cuoghi Costantini
raw_affiliation_strings: Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy
raw_author_name: Elena Tenedini
raw_affiliation_strings: Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy
raw_author_name: Ornella Ponzoni
raw_affiliation_strings: Department of Medical Oncology, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy
Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy
raw_author_name: Maria Grazia Razeti
raw_affiliation_strings: Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy
raw_author_name: Caterina Sposetti
raw_affiliation_strings: Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA
Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
raw_author_name: Elena Barbieri
raw_affiliation_strings: Department of Medical Oncology, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy
raw_author_name: Martina Manni
raw_affiliation_strings: Department of Medical Oncology, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy
raw_author_name: Federica Caggia
raw_affiliation_strings: Department of Medical Oncology, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy
raw_author_name: Laura Cortesi
raw_affiliation_strings: Department of Medical Oncology, AUSL-IRCCS Reggio Emilia, Reggio Emilia, Italy
Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy
raw_author_name: Giuseppe Curigliano
raw_affiliation_strings: Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy
Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy
raw_author_name: Emilio Bria
raw_affiliation_strings: Ospedale Isola Tiberina-Gemelli Isola, Rome, Italy
Università Cattolica del Sacro Cuore, Rome, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
raw_author_name: Massimo Dominici
raw_affiliation_strings: Department of Medical Oncology, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy
Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy
raw_author_name: Valentina Guarneri
raw_affiliation_strings: Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy
Division of Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy
raw_author_name: Matteo Lambertini
raw_affiliation_strings: Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genoa, Genoa, Italy
Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy
raw_author_name: Angela Toss
raw_affiliation_strings: Department of Medical Oncology, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy. angela.toss@unimore.it
Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy. angela.toss@unimore.it